Hugh Bender is a Postdoctoral Research Fellow in the Chris Hughes Lab at the University of California, Irvine. He is also Lead Scientist at Aracari Biosciences. Dr. Bender received his PhD in 2015 from Washington University in St. Louis. His research focuses on developing a novel micro-vascularized organ system for modeling Type I diabetes in the lab. Dr. Bender is an active member of CHIB and a member of the HIRN Technical User Group.
Bridget Wagner is the Director of Pancreatic Cell Biology and Metabolic Disease in the Chemical Biology and Therapeutic Sciences Program at the Broad Institute of MIT and Harvard, where she is also an institute scientist. Her research focuses on the chemical biology of diabetes, with the aim of identifying small molecules capable of increasing pancreatic beta cell number and function and the ultimate goal of discovering new therapeutic approaches for diabetes. Dr. Wagner is the chair of the Consortium of Targeting and Regeneration (CTAR) and the Trans-Network Committee (TNC).